Radiosynthesis and preclinical evaluations of [18F]AlF-RESCA-5F7 as a novel molecular probe for HER2 tumor imaging
American Journal of Nuclear Medicine and Molecular Imaging · 2024
DOI: 10.62347/bvpk1360 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Ruhua Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Basic Medicine, Guizhou Medical University Guiyang 550009, Guizhou, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, School of Basic Medicine, Guizhou Medical University Guiyang 550009, Guizhou, China.
- Institute of Radiation Medicine, Fudan University No. 2094 Xietu Road, Shanghai 200032, China.
Zitieren
APA
Tian, R., Kong, J., He, Y., Xu, G., Chen, T., & Han, J. (2024). Radiosynthesis and preclinical evaluations of [18F]AlF-RESCA-5F7 as a novel molecular probe for HER2 tumor imaging. American Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.62347/bvpk1360
Vancouver
Tian R, Kong J, He Y, Xu G, Chen T, Han J. Radiosynthesis and preclinical evaluations of [18F]AlF-RESCA-5F7 as a novel molecular probe for HER2 tumor imaging. American Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.62347/bvpk1360
BibTeX
@article{Tian2024,
author = {Tian, Ruhua and Kong, Jinping and He, Yingfang and Xu, Guoqiang and Chen, Tengxiang and Han, Junbin},
title = {Radiosynthesis and preclinical evaluations of [18F]AlF-RESCA-5F7 as a novel molecular probe for HER2 tumor imaging},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
doi = {10.62347/bvpk1360}
}
EUVIMED